Fabtech Technologies — a turnkey engineering solutions provider for the pharmaceuticals, biotech and healthcare industry — has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering.
The Mumbai-based company’s proposed initial public offering (IPO) is entirely a fresh issue of up to 1.20 crore equity shares. The offer also includes a reservation for a subscription by eligible employees, according to the draft red herring prospectus (DRHP).
The company may raise up to Rs 10 crore through the pre-IPO round. If such placement is completed, the fresh issue size will be reduced.
Proceeds from the IPO to the extent of Rs 120 crore will be used for funding the working capital requirements of the company, and Rs 30 crore for pursuing inorganic growth initiatives through acquisitions, and general corporate purposes.
Fabtech Technologies, part of the Fabtech Group was incorporated as Globeroute Ventures Private Ltd. The company demerg
Posts in category Business Standard
Fabtech Technologies files draft papers with Sebi to raise funds via IPO (16-09-2024)
Sensex, Nifty end with minor gains; media shares outperform (16-09-2024)
The domestic equity indices ended with limited gains on Monday. The Nifty traded above the 25,300 level after hitting the days low of 25,336.20 in early afternoon trade. Media, metal and realty shares advanced while FMCG, IT and pharma shares declined.
Strides Pharma hits record high after arm gets USFDA nod for antidepressant drug (16-09-2024)
Strides Pharma Science rallied 3.13% to Rs 1,395.80 after the company’s step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore has received US Food & Drug Administration (USFDA) approval for Fluoxetine tablets.
Pound speculators net long positions off 5-week high (16-09-2024)
Large currency speculators reduce net long position in the Pound futures, according to the latest Commitment of Traders (COT) data released by the Commodity Futures Trading Commission (CFTC). The non-commercial futures contracts of Pound futures, traded by large speculators and hedge funds, totaled a net long position of 90288 contracts in the data reported through September 10, 2024. This was a weekly decrease of 17790 net contracts and off its highest level in 5 weeks.
Laurus Labs inaugurates new R&D center at IKP Knowledge Park (16-09-2024)
Key highlights:
– Total investment incurred for setting up the new R&D Rs 250 crore
– 2,00,000 Square foot facility equipped with modern laboratories and infrastructure
– R&D Center to support the CDMO business of Laurus Labs
– Will provide job opportunities to over 800 people
BSE zooms 19% on heavy volumes; MCX surges 8% on positive outlook (16-09-2024)
The outlook for Indian equities market in FY25 appears promising, supported by various factors such as economic recovery, stable government, increased focus on reforms, and rise foreign investments.
Shyam Metalics sets up new Cold Rolling Mill (CRM) in Jamuria, West Bengal (16-09-2024)
Shyam Metalics & Energy announced the expansion of its production capabilities with the establishment of a state-of-the-art Greenfield Cold Rolling Mill (CRM) in Jamuria, West Bengal. This strategic investment highlights Shyam Metalics’ commitment to enhancing its product portfolio and extending its reach in both domestic and international markets.
Strides receives USFDA approval for Fluoxetine Tabs 60 mg (16-09-2024)
Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global, Singapore, has received approval for Fluoxetine Tabs 60 mg, from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Fluoxetine Tablets, 60 mg, of TWi Pharmaceuticals, Inc.
Australian markets hit record high (16-09-2024)
Energy and healthcare stocks lagged, helping limit overall gains in the broader market. The benchmark S&P/ASX 200 rose 0.27 percent to 8,121.60 while the broader All Ordinaries index finished 0.21 percent higher at 8,341.10.
Major Asian markets closed for holidays, China economic data disappoints (16-09-2024)
Upcoming U.S. retail sales and industrial production data also remained on investors’ radar.